» Articles » PMID: 35460513

Does a Hypertrophying Muscle Fibre Reprogramme Its Metabolism Similar to a Cancer Cell?

Overview
Journal Sports Med
Specialty Orthopedics
Date 2022 Apr 23
PMID 35460513
Authors
Affiliations
Soon will be listed here.
Abstract

In 1924, Otto Warburg asked "How does the metabolism of a growing tissue differ from that of a non-growing tissue?" Currently, we know that proliferating healthy and cancer cells reprogramme their metabolism. This typically includes increased glucose uptake, glycolytic flux and lactate synthesis. A key function of this reprogramming is to channel glycolytic intermediates and other metabolites into anabolic reactions such as nucleotide-RNA/DNA synthesis, amino acid-protein synthesis and the synthesis of, for example, acetyl and methyl groups for epigenetic modification. In this review, we discuss evidence that a hypertrophying muscle similarly takes up more glucose and reprogrammes its metabolism to channel energy metabolites into anabolic pathways. We specifically discuss the functions of the cancer-associated enzymes phosphoglycerate dehydrogenase and pyruvate kinase muscle 2 in skeletal muscle. In addition, we ask whether increased glucose uptake by a hypertrophying muscle explains why muscularity is often negatively associated with type 2 diabetes mellitus and obesity.

Citing Articles

Skeletal muscle growth to combat diabetes and obesity: the potential role of muscle-secreted factors.

Sammut M, Thorne B, Melling C Obesity (Silver Spring). 2025; 33(3):435-451.

PMID: 39948829 PMC: 11897867. DOI: 10.1002/oby.24223.


Exploring glycolytic enzymes in disease: potential biomarkers and therapeutic targets in neurodegeneration, cancer and parasitic infections.

Rojas-Pirela M, Andrade-Alviarez D, Rojas V, Marcos M, Salete-Granado D, Chacon-Arnaude M Open Biol. 2025; 15(2):240239.

PMID: 39904372 PMC: 11793985. DOI: 10.1098/rsob.240239.


microRNA-1 Regulates Metabolic Flexibility in Skeletal Muscle via Pyruvate Metabolism.

Ismaeel A, Peck B, Montgomery M, Burke B, Goh J, Kang G bioRxiv. 2024; .

PMID: 39149347 PMC: 11326265. DOI: 10.1101/2024.08.09.607377.


Skeletal muscle hypertrophy: cell growth is cell growth.

Burke B, Ismaeel A, von Walden F, Murach K, McCarthy J Am J Physiol Cell Physiol. 2024; 327(3):C614-C618.

PMID: 39069829 PMC: 11901336. DOI: 10.1152/ajpcell.00418.2024.


The utility of the rodent synergist ablation model in identifying molecular and cellular mechanisms of skeletal muscle hypertrophy.

Burke B, Ismaeel A, McCarthy J Am J Physiol Cell Physiol. 2024; 327(3):C601-C606.

PMID: 39069822 PMC: 11427019. DOI: 10.1152/ajpcell.00362.2024.


References
1.
Warburg O, Wind F, Negelein E . THE METABOLISM OF TUMORS IN THE BODY. J Gen Physiol. 2009; 8(6):519-30. PMC: 2140820. DOI: 10.1085/jgp.8.6.519. View

2.
RACKER E . Bioenergetics and the problem of tumor growth. Am Sci. 1972; 60(1):56-63. View

3.
Lunt S, Vander Heiden M . Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol. 2011; 27:441-64. DOI: 10.1146/annurev-cellbio-092910-154237. View

4.
DeBerardinis R, Chandel N . Fundamentals of cancer metabolism. Sci Adv. 2016; 2(5):e1600200. PMC: 4928883. DOI: 10.1126/sciadv.1600200. View

5.
Warburg O . On respiratory impairment in cancer cells. Science. 1956; 124(3215):269-70. View